BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect
Authors:
- 1 March 2004
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 3 (1) , 15-20
Abstract
Objective: The purpose of this study was to determine whether two mutations detected frequently in a population of breast and/or ovarian cancer families originating from the northeastern part of France could be due to a founder effect. Methods: 83 index cases of families ascertained to have a familial breast and/or ovarian cancer history, were screened for mutations in all coding exons of the BRCA1 gene, using combined DGGE and direct sequencing. For haplotype analysis, six polymorphic markers were used for allelotyping of mutation carriers and non carriers from nine families with 3600del11 mutation and four families with G1710X mutation. Results: Of 83 index cases, 27 (32%) had 14 different BRCA1 mutations, one of which (G1710X), had not been reported in other populations. Two mutations were particularly common: 3600del11 in exon 11 accounted for 37% and the nonsense mutation G1710X in exon 18 for 15% of all mutations. We identified a common haplotype for each mutation suggesting a common founder for each recurrent mutation. No specific phenotype could be assigned to any of the common mutations. Conclusions: These data demonstrate geographical clustering and suggest a founder effect for particular BRCA1 mutations, which identification will facilitate carrier detection in French families with breast cancer and breast and/or ovarian cancer.Keywords
This publication has 33 references indexed in Scilit:
- BRCA1 RING Domain Cancer-predisposing MutationsJournal of Biological Chemistry, 2001
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerThe American Journal of Human Genetics, 2000
- Evidence for a BRCA1 Founder Mutation in Families of West African AncestryThe American Journal of Human Genetics, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern FranceEuropean Journal Of Cancer Prevention, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNature Genetics, 1996
- Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNature Genetics, 1994
- A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1Human Molecular Genetics, 1994